Skip to main content
Caplight Logo









Innovac Therapeutics

Innovac Therapeutics

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.innovactx.com/

Last Round

Early Funding

Sep 1, 2023

Total Funding Raised

$18M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Innovac Therapeutics is a biotechnology company that develops mRNA-based vaccines and therapeutics for oncology and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

mRNA therapeuticslipid nanoparticleLNPmRNA vaccinedrug discoverybiotech platformmRNA designneoantigen designbiotech CDMOcomputational biologymRNA manufacturingvaccine developmentpreclinical researchimmunology assaybiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Innovac Therapeutics Comparables

Compare Innovac Therapeutics with similar companies based on industry and business-model similarity.

Innovac Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RNAimmune
88%
Shanghai RNACure Biopharma Co., Ltd.
83%
Innorna
81%

Innovac Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 1, 2023

Key People

Founding team and executive leadership

Chi Zhang

Chief Executive Officer, Co-Founder

Founding Team

Innovac Therapeutics Investors

Notable investors and investment history

Innovac Therapeutics investors
InvestorRounds
Yuanjing CapitalEarly Funding
Yunion Health InvestmentsEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 140% MoM, reaching 1.3K.

  • Apr 20, 2026

    Monthly visitors grew 64% MoM, from 1.2K to 2K.

Innovac Therapeutics Filings

Explore SEC and related filing metadata, where available.

Innovac Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Innovac Therapeutics's valuation, stock price, and market status.

Is Innovac Therapeutics a public or private company?

Innovac Therapeutics is a private company.

What is the current stock price of Innovac Therapeutics?

Innovac Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Innovac Therapeutics worth (valuation)?

Valuation information for Innovac Therapeutics is not publicly available.

Can I buy Innovac Therapeutics stock?

Innovac Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Innovac Therapeutics's last funding round?

Innovac Therapeutics's most recent funding round was Early Funding on September 1, 2023.

Who are the main investors in Innovac Therapeutics?

Key investors in Innovac Therapeutics include Vision Plus Capital.

Will Innovac Therapeutics IPO soon?

No public IPO plans have been announced for Innovac Therapeutics.

How can I track Innovac Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Innovac Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range14
Year Founded2022
Last FundingSep 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?